The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]

  • See Evidence submitted by expert panel for details.

Variant: NM_000277.1(PAH):c.1114A>T (p.Thr372Ser)

CA229350

102528 (ClinVar)

Gene: PAH
Condition: phenylketonuria
Inheritance Mode: Autosomal recessive inheritance
UUID: d7e037fb-45b7-488f-98bc-920b7c13f9eb

HGVS expressions

NM_000277.1:c.1114A>T
NM_000277.1(PAH):c.1114A>T (p.Thr372Ser)
NC_000012.12:g.102843731T>A
CM000674.2:g.102843731T>A
NC_000012.11:g.103237509T>A
CM000674.1:g.103237509T>A
NC_000012.10:g.101761639T>A
NG_008690.1:g.78872A>T
NG_008690.2:g.119680A>T
ENST00000553106.6:c.1114A>T
ENST00000307000.7:c.1099A>T
ENST00000549247.6:n.873A>T
ENST00000551114.2:n.776A>T
ENST00000553106.5:c.1114A>T
ENST00000635477.1:n.218A>T
ENST00000635528.1:n.629A>T
NM_000277.2:c.1114A>T
NM_001354304.1:c.1114A>T
NM_000277.3:c.1114A>T
NM_001354304.2:c.1114A>T
NM_000277.3(PAH):c.1114A>T (p.Thr372Ser)

Likely Pathogenic

Met criteria codes 3
PP4_Moderate PM2 PM3_Strong
Not Met criteria codes 2
PP3 PM5

Evidence Links 2

Expert Panel

Criteria Specification Information

Criteria Specifications for this VCEP
Evidence submitted by expert panel
Phenylketonuria VCEP
The c.1114A>T (p.Thr372Ser) variant in PAH has been reported in multiple individuals with PAH deficiency (BH4 deficiency excluded, PMID: 8807319, 21147011, 30050108). This variant has an extremely low frequency in gnomAD (MAF=0.00001). This variant was detected with multiple pathogenic/likely pathogenic variants: p.R408W, c.1066-11G>A (PMID: 21147011); p.A300S (PMID: 8807319); p.P281L (2 patients, LP), delF39 (PMID: 10947211). Computational evidence is conflicting. In summary, this variant meets criteria to be classified as likely pathogenic for PAH. PAH-specific ACMG/AMP criteria applied: PP4_Moderate, PM2, PM3_strong.
Met criteria codes
PP4_Moderate
T372S was found in 1 Turkish patient with HPA (PMID: 8807319), and 3 PKU patients where BH4 deficiency had been ruled out by assessment of PAH gene and genes of the BH4 synthesis/recycling pathways (PTS and QDPR). PMID: 21147011; 1 CHinese patient with MHP, dihydropteridine reductase activity, urinary biopterin and neopterin ratio were assessed PMID: 30050108 2.5 pts

PM2
Absent from ExAC, 1000G, ESP. Extremely low frequency in gnomAD (MAF=0.00001)
PM3_Strong
Seen with 5 pathogenic variants: R408W, IVS10-11G>A (parental analysis not reported, PMID: 21147011); A300S (parental analysis not reported, PMID: 8807319); P281L (2 patients, LP), delF39 (P 5 submitters) parental analysis not reported PMID: 10947211 2.5 pts

Not Met criteria codes
PP3
Conflicting predictions of pathogenicity: deleterious in SIFT and MutationTaster, benign in Polyphen2, REVEL=0.908
PM5
This variant is the only variant found in this codon in ClinVar.
Approved on: 2020-08-14
Published on: 2021-11-21
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.